Skip to main content

Table 3 Clinical Characteristics and laboratory profile of ART patients in relation to the parasite positivity rate in St. Mary Aksum General Hospital, from March to April 2017 Tigray, Ethiopia

From: Intestinal parasitosis in relation to CD4 count and anemia among ART initiated patients in St. Mary Aksum general hospital, Tigray, Ethiopia

Variables

 

Frequency (%)

Positive to IPIs, n (%)

Start of ART

Less than one year

11(4.5)

4(36.4)

before one year

231(95.5)

60(26.0)

Current WHO HIV stage

I

236 (97.5)

63(26.7)

II

3(1.2)

1(33.3)

III

3(1.2)

0(0.0)

Type of ARV drug

First line

224(92.6)

57(25.4)

Second line

18(7.4)

7(38.9)

Category of CD4 now

< 200

39(16.1)

18(46.2)

200–500

69(28.5)

16(23.2)

500+

134(55.4)

30(22.4)

Stool consistency

Formed

69(28.5)

8(11.6)

Soft

101(41.7)

26(25.7)

Loose

44(18.2)

17(38.6)

Diarrheic

28(11.6)

13(46.4)

Diarrhea condition

No diarrhea

214(88.4)

51(23.8)

Chronic

17(7.0)

8(47.1)

Acute

11(4.6)

5(45.5)

Anemia status

No anemia

215(88.8)

49(22.8)

Mild

20(8.3)

10(50.0)

Moderate

7(2.9)

5(71.4)

Presence of Parasites

Yes

64(26.4)

64(26.4)

No

178(73.6)

178(73.6)

Total

 

242(100)

64 (26.4%)

  1. Note: ART Antiretroviral Therapy, ARV Antiretroviral, IPs Intestinal parasites